Annual Review of Pharmacology

Por Bertino, Joseph R.
Publicado em 1967

Alan Sartorelli: A Personal Remembrance

Por Bertino, Joseph R.
Publicado no Oncologist (2015)

Impaired utilization of serum folate in pernicious anemia: A study with radiolabeled 5-methyltetrahydrofolate

Por Nixon, Peter F., Bertino, Joseph R.
Publicado em 1972

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

Por Hryniuk, William M., Bertino, Joseph R.
Publicado em 1969

MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine

Por Mishra, Prasun J, Bertino, Joseph R
Publicado em 2009

6-Thioguanine: A Drug With Unrealized Potential for Cancer Therapy

Por Munshi, Pashna N., Lubin, Martin, Bertino, Joseph R.
Publicado em 2014

Overexpression of the Mitochondrial Folate and Glycine–Serine Pathway: A New Determinant of Methotrexate Selectivity in Tumors

Por Vazquez, Alexei, Tedeschi, Philip M., Bertino, Joseph R.
Publicado em 2012

Intestinal Folate Absorption: II. CONVERSION AND RETENTION OF PTEROYLMONOGLUTAMATE BY JEJUNUM

Por Olinger, Edward J., Bertino, Joseph R., Binder, Henry J.
Publicado em 1973

Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: Current strategies

Por Bertino, Joseph R, Waud, William R, Parker, William B, Lubin, Martin
Publicado em 2011

Mitochondrial Methylene Tetrahydrofolate Dehydrogenase (MTHFD2) Overexpression is Associated with Tumor Cell Proliferation and is a Novel Target for Drug Development

Por Tedeschi, Philip M., Vazquez, Alexei, Kerrigan, John E., Bertino, Joseph R.
Publicado no Mol Cancer Res (2015)

MTHFD2- a new twist?

Por Tedeschi, Philip M., Scotto, Kathleen W., Kerrigan, John, Bertino, Joseph R.
Publicado no Oncotarget (2016)

Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma

Por Casper, Ephraim S., Schwartz, Gary M., Leung, Denis, Sugarman, Alison, Bertino, Joseph R.
Publicado em 1999

Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts

Por Tedeschi, Philip M., Kathari, Yamini K., Farooqi, Iqra N., Bertino, Joseph R.
Publicado em 2014

Methylthioadenosine phosphorylase (MTAP)-deficient T-cell ALL xenografts are sensitive to pralatrexate and 6-thioguanine alone and in combination

Por Tedeschi, Philip M., Kathari, Yamini K., Johnson-Farley, Nadine, Bertino, Joseph R.
Publicado no Cancer Chemother Pharmacol (2015)

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells

Por Bansal, Nitu, Mishra, Prasun J., Stein, Mark, DiPaola, Robert S., Bertino, Joseph R.
Publicado no Oncotarget (2015)

A Novel Antibody-Toxin Conjugate to Treat Mantle Cell Lymphoma

Por Rather, Gulam M., Lin, Siang-Yo, Lin, Hongxia, Szekely, Zoltan, Bertino, Joseph R.
Publicado no Front Oncol (2019)

NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview

Por Pramono, Alvinsyah Adhityo, Rather, Gulam M., Herman, Herry, Lestari, Keri, Bertino, Joseph R.
Publicado no Biomolecules (2020)

A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

Por Mishra, Prasun J., Humeniuk, Rita, Mishra, Pravin J., Longo-Sorbello, Giuseppe S. A., Banerjee, Debabrata, Bertino, Joseph R.
Publicado em 2007

Translational Modulation of Proteins Expressed from Bicistronic Vectors

Por Mishra, Prasun J., Menon, Lata G., Mishra, Pravin J., Mayer-Kuckuk, Philipp, Bertino, Joseph R., Banerjee, Debabrata
Publicado em 2009

A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studies

Por Lin, Hongxia, Gounder, Murugesan K., Bertino, Joseph R., Kong, Ah-Ng Tony, DiPaola, Robert S., Stein, Mark N.
Publicado em 2012